These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30280776)

  • 1. LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107.
    Qian B; Wang DM; Gu XS; Zhou K; Wu J; Zhang CY; He XY
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5946-5953. PubMed ID: 30280776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p.
    Wu JL; Meng FM; Li HJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5938-5945. PubMed ID: 30280775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-19a promotes proliferative and migratory abilities of NSCLC cells by inhibiting PTEN expression.
    Shi J; Han Y; Lin D; Wang K; Liu B; Gao C
    J BUON; 2019; 24(3):955-962. PubMed ID: 31424647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p.
    Qu CX; Shi XC; Zai LQ; Bi H; Yang Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):247-255. PubMed ID: 31389608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
    Chen ZY; Liu HY; Jiang N; Yuan JM
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer.
    Zheng ZH; Wu DM; Fan SH; Zhang ZF; Chen GQ; Lu J
    J Cell Biochem; 2019 Nov; 120(11):18724-18735. PubMed ID: 31219199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
    Ma XR; Xu YL; Qian J; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
    Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
    Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXF2 aggravates the progression of non-small cell lung cancer through targeting lncRNA H19 to downregulate PTEN.
    Xu JL; Hua T; Ding J; Fan Y; Liu ZJ; Lian JW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10796-10802. PubMed ID: 31858547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
    Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.
    Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
    Hao XZ; Yang K
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancer.
    Zhou Y; Sheng B; Xia Q; Guan X; Zhang Y
    Cancer Gene Ther; 2017 Aug; 24(8):317-324. PubMed ID: 28799568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p.
    Li SJ; Wu YX; Liang YH; Gao Y; Wu AB; Zheng HY; Yang ZX
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):704-711. PubMed ID: 32016972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
    Wang T; Li W; Li W; Liu L; Zhang H
    J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17.
    Huang Z; Lei W; Hu HB; Zhang H; Zhu Y
    J Cell Physiol; 2018 Oct; 233(10):6768-6776. PubMed ID: 29693721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-217 alleviates development of non-small cell lung cancer by inhibiting AKT3 via PI3K pathway.
    Qi YJ; Zha WJ; Zhang W
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5972-5979. PubMed ID: 30280779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.